Jean-Luc Villeval

Publications

Article dans une revue (10)

Impaired fibrinolysis in JAK2V617F-related myeloproliferative neoplasms Marie-Charlotte Bourrienne,Stéphane Loyau,Dorothée Faille,Juliette Gay,Séléna Akhenaket al. Journal of Thrombosis and Haemostasis, 2024, 22 (11), pp.3199-3208. ⟨10.1016/j.jtha.2024.07.031⟩ Article dans une revue hal-05269716v1
SRSF2-P95H decreases JAK/STAT signaling in hematopoietic cells and delays myelofibrosis development in mice Christophe Willekens,Lucie Laplane,Tracy Dagher,Camelia Benlabiod,Nicolas Papadopouloset al. Leukemia, 2023, 37 (6), pp.1287-1297. ⟨10.1038/s41375-023-01878-0⟩ Article dans une revue hal-04430024v1
In Vivo Monitoring of Polycythemia Vera Development Reveals Carbonic Anhydrase 1 as a Potent Therapeutic Target Shohei Murakami,Vilma Barroca,Leïla Perié,Anne Bravard,Jacqueline Bernardino-Sgherriet al. Blood Cancer Discovery, 2022, 3 (4), pp.285-297. ⟨10.1158/2643-3230.BCD-21-0039⟩ Article dans une revue hal-03800965v1
Inferring the dynamic of mutated hematopoietic stem and progenitor cells induced by IFNα in myeloproliferative neoplasms Matthieu Mosca,Gurvan Hermange,Amandine Tisserand,Robert John Noble,Christophe Marzacet al. Blood, 2021, ⟨10.1182/blood.2021010986⟩ Article dans une revue hal-03452002v1
PPARγ agonists promote the resolution of myelofibrosis in preclinical models Juliette Lambert,Joseph Saliba,Carolina Calderón,Karine Sii-Felice,Mohammad Salmaet al. The Journal of clinical investigation, 2021, 131 (11), ⟨10.1172/JCI136713⟩ Article dans une revue hal-04429976v1
Megakaryocytes tame erythropoiesis with TGFβ1 Jean-Luc Villeval,William Vainchenker Blood, 2020, 136 (9), pp.1016-1017. ⟨10.1182/blood.2020006906⟩ Article dans une revue hal-04470954v1
Erythrocyte-derived microvesicles induce arterial spasms in JAK2V617F myeloproliferative neoplasm Johanne Poisson,Marion Tanguy,Hortense Davy,Fatoumata Camara,Marie-Belle El Mdawaret al. Journal of Clinical Investigation, 2020, 130 (5), pp.2630-2643. ⟨10.1172/JCI124566⟩ Article dans une revue hal-04031547v1
JAK2V617F myeloproliferative neoplasm eradication by a novel interferon/arsenic therapy involves PML Tracy Dagher,Nabih Maslah,Valérie Edmond,Bruno Cassinat,William Vainchenkeret al. Journal of Experimental Medicine, 2020, 218 (2), pp.e20201268. ⟨10.1084/jem.20201268⟩ Article dans une revue hal-04055414v1
1017 – INVESTIGATING THE MECHANISMS OF IFNALPHA THERAPY IN JAK2V617F AND CALR MUTATED MYELOPROLIFERATIVE NEOPLASMS Isabelle Plo,Amandine Tisserand,Robert Noble,Tracy Dagher,Nabih Maslahet al. Experimental Hematology, 2020, 88, pp.S22. ⟨10.1016/j.exphem.2020.09.016⟩ Article dans une revue hal-05469740v1
Comparison of endothelial promoter efficiency and specificity in mice reveals a subset of Pdgfb‐positive hematopoietic cells Johanne Poisson,Marion Tanguy,Hortense Davy,Fatoumata Camara,Marie-Belle El Mdawaret al. Journal of Thrombosis and Haemostasis, 2019, 17 (5), pp.827-840. ⟨10.1172/JCI124566⟩ Article dans une revue hal-04477329v1

Poster de conférence (1)

Increased myelofibrosis in Thrombospondin-1-null mice is associated with enhanced TGF-ß1 mediated response by bone marrow fibroblasts Solène M Evrard,Micheline Tulliez,Eva Zetterberg,Jan Palmblad,William Vainchenkeret al. ASH, Nov 2008, San Francisco CA, France Poster de conférence hal-04940586v1